HS code : 3001.20.90002 w* d0 k+ ~& |+ `2 `, D
keywords : Stem Cells, Heart failure, Heart Disease, Bone marrow, Mesenchymal stem cells, Myocardial infarction, Left Ventricular ejection Fraction (LVEF)9 c- g' O/ \2 }+ }# a
l7 c4 N$ V. d) [
World’s First Stem Cell Therapy Product “Hearticellgram®-AMI” 7 z; i6 ?4 H; P% s
Pharmicell has successfully developed the world’s first stem cell therapeutics and received NDA approval from the KFDA in July 1, 2011. Hearticellgram-AMI uses autologous stem cells and is a personalized stem cell therapy product which overcomes immune rejection and ethical dilemmas. 0 @- d- c, l& C+ v& U! M9 ^Stem cells can become any type of cells or tissue in the body, just like a parent cell. Stem cells have a multipotent capability that allows them able to divide repeatedly, self-renew, and be differentiated into different types of cells. Thus stem cells can produce certain organs and tissues. Stem cell therapeutics is a therapy that can be used to repair malfunctioning or damaged cells and tissue by injecting autologous adult stem cells when a disease is diagnosed. The effectiveness of stem cell therapeutics has been proved in various incurable diseases such as heart disease, cerebral diseases, and cancer.. ~! }% J# S. a/ [